The immunoreactive staining of PNPO was weak in normal tissues of the ovary and the fallopian tube and benign tumour, moderate in borderline tumour and strong in malignant tumours, including serous, mucinous, endometrioid, clear cell and transitional cell carcinomas. This evidence concerns the gene PNPO and transitional cell carcinoma.